Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass.
Paulo Roberto B
PR
Evora
Ricardo L
RL
Levin
D000818:Animals; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D002395:Catecholamines / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006162:Guanylate Cyclase / Q000037:antagonists & inhibitors; D006801:Humans; D008751:Methylene Blue / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000188:drug therapy*; D014655:Vascular Resistance / Q000187:drug effects*
D002395:Catecholamines; D004791:Enzyme Inhibitors; D006162:Guanylate Cyclase; D008751:Methylene Blue